Cannabinoid receptors and T helper cells

Journal of Neuroimmunology

Volumn 147, Issue 1-2, 2004, Pages 91-94

  Klein, Thomas W ^a   Newton, Cathy ^a   Larsen, Kellie ^a   Chou, Joe ^a   Perkins, Izabella ^a   Lu, Lily ^a   Nong, Liang ^a   Friedman, Herman ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cannabinoid; IL 12; Th1 cells

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; BORNANE DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; DNA BINDING PROTEIN; GAMMA INTERFERON; GATA 3 FACTORS; GATA-3 FACTORS; GENE PRODUCT; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA2; INTERLEUKIN RECEPTOR; INTERLEUKIN-2 RECEPTOR BETA2; MESSENGER RNA; PIPERIDINE DERIVATIVE; PSYCHOTROPIC AGENT; PYRAZOLE DERIVATIVE; RECEPTOR SUBTYPE; RIMONABANT; TETRAHYDROCANNABINOL; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ALLOTYPE SUPPRESSION; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL INFECTION; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; EXPERIMENTAL INFECTION; GENETICS; HELPER CELL; IMMUNOLOGY; IMMUNOREGULATION; LEGIONELLA PNEUMOPHILA; METABOLISM; METHODOLOGY; MICROBIOLOGY; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROVOCATION TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; TH1 CELL; TH2 CELL; THERMAL ANALYSIS;

EID: 1642575043     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.10.019     Document Type: Conference Paper

References (20)

1. Bayewitch M., Avidor-Reiss T., Levy R., Barg J., Mechoulam R., Vogel Z. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Lett. 375:1995;143-147.
2. i protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Mol. Pharmacol. 55:1999;473-480.
3. Braun M.C., Kelsall B.L. Regulation of interleukin-12 production by G-protein-coupled receptors. Microbes Infect. 3:2001;99-107.
4. Chang J.T., Shevach E.M., Segal B.M. Regulation of interleukin (IL)-12 receptor β2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreacitve T cells. J. Exp. Med. 189:1999;969-978.
5. Cohen M., Klein E., Kuten A., Fried G., Zinder O., Pollack S. Increased emotional distress in daughters of breast cancer patients is associated with decreased natural cytotoxic activity, elevated levels of stress hormones and decreased secretion of Th1 cytokines. Int. J. Cancer. 100:2002;347-354.
6. Das J., Chen C.-H., Yang L., Cohn L., Ray P., Ray A. A critical role for NF-kB in Gata3 expression and Th2 differentiation in allergic airway inflammation. Nat. Immunol. 2:2001;45-50.
7. Felder C.C., Joyce K.E., Briley E.M., Glass M., Mackie K.P., Fahey K.J., Cullinan G.J., Hunden D.C., Johnson D.W., Chaney M.O., Koppel G.A., Brownstein M. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J. Pharmacol. Exp. Ther. 284:1998;291-297.
8. Klein T., Newton C., Friedman H. Cannabinoid receptors and immunity. Immunol. Today. 19:1998;373-381.
9. 9-Tetrahydrocannabinol treatment suppresses immunity and early IFN-γ, IL-12, and IL-12 receptor β2 responses to Legionella pneumophila infection. J. Immunol. 164:2000;6461-6466.
10. Klein T.W., Newton C.A., Friedman H. Cannabinoids and the immune system. Pain Res. Manag. 6:2001;95-101.
11. Kuroda E., Sugiura T., Zeki K., Yoshida Y., Yamashita U. Sensitivity difference to the suppressive effect of prostaglandin E among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice. J. Immunol. 164:2000;2386-2395.
12. Moser M., Murphy K. Dendritic cell regulation of Th1-Th2 development. Nat. Immunol. 1:2000;199-205.
13. Newton C.A., Klein T.W., Friedman H. Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect. Immun. 62:1994;4015-4020.
14. Ouyang W., Ranganath S.H., Weindel K., Bhattacharya D., Murphy T.L., Sha W.C., Murphy K.M. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 9:1998;745-755.
15. Roy S., Balasubramanian S., Sumandeep S., Charboneau R., Wang J., Melnyk D., Beilman G.J., Vatassery R., Barke R.A. Morphine directs T cells toward T(H2) differentiation. Surgery. 130:2001;304-309.
16. Smith S.R., Terminelli C., Denhardt G. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands. Eur. J. Pharmacol. 425:2001;73-83.
17. Swanson M.A., Lee W.T., Sanders V.M. IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine. J. Immunol. 166:2001;232-240.
18. Szabo S.J., Dighe A.S., Gubler U., Murphy K.M. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:1997;817-824.
19. 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J. Neuroimmunol. 133:2002;124-131.
20. Zhu L.X., Sharma S., Stolina M., Gardner B., Roth M.D., Tashkin D.P., Dubinett S.M. Δ-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol. 165:2000;373-380.